The Vermedx® Diabetes Information System Reduces Healthcare Utilization
Benjamin Littenberg, MD; Charles D. MacLean, MDCM; Karl Zygarowski, BS; Barbara H. Drapola, RN; James A. Duncan, MD; and Clifford R. Frank, MHSA
Am J Manag Care. 2009;15(3):166-170
Published Online: March 16, 2009 - 12:00:07 AM (CDT)
It shows that the savings estimated in the NIH clinical trial of Vermedx® are confirmed in an analysis of managed care claims paid. I posted the abstract and a key figure Sunday. Here is the table showing the savings that are generated when patients are enrolled in the Vermedx® Diabetes Information System.
Table 2: Net savings per patient as a function of duration of the VDIS program
Duration
(months)
Monthly
savings
Annual
Savings
Cumulative
savings
12
$80.96
$504.24
$504.24
24
$165.92
$1,523.76
$2,028.00
36
$250.88
$2,543.28
$4,571.28
48
$335.84
$3,562.80
$8,134.08
Savings are calculated net of the costs of the program.
For more information, please see www.Vermedx.com.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.